生物技术进展 ›› 2015, Vol. 5 ›› Issue (6): 420-424.DOI: 10.3969/j.issn.20952341.2015.06.03

• 综述 • 上一篇    下一篇

双特异性抗体药物应用进展

李耿,刘晓志,王志明,高健*   

  1. 华北制药集团新药研究开发有限责任公司, 抗体药物研制国家重点实验室, 石家庄 050015
  • 收稿日期:2015-09-08 修回日期:2015-09-25 出版日期:2015-11-25 发布日期:2015-09-25
  • 通讯作者: 高健,高级工程师,主要从事蛋白药物研发。E-mail: gaojian3993@aliyun.com
  • 作者简介:李耿,工程师,主要从事蛋白药物研发。E-mail: 13073182298@163.com。
  • 基金资助:

    国家科技重大专项项目( 2012ZX09101313) ;河北省重大科技成果转化专项(13042404Z)资助。

Application of Bispecific Antibody Drugs

LI Geng, LIU Xiao-zhi, WANG Zhi-ming, GAO Jian   

  1. State Key Laboratory of Antibody Research & Development; New Drug Research and Development Company LTD., North China Pharmaceutical Corporation, Shijiazhuang 050015, China
  • Received:2015-09-08 Revised:2015-09-25 Online:2015-11-25 Published:2015-09-25

摘要: 基因工程的飞速发展推动了新型双功能抗体药物的成功研制。目前双功能抗体药物主要应用于肿瘤的免疫治疗、自身免疫疾病和感染类疾病的治疗,在组织再生和临床诊断领域也有应用。就双特异性抗体的发展史进行了简要回顾,对其在免疫治疗、组织再生和临床诊断等领域中的应用进展进行了综述,并展望了未来的发展方向,以期为新型双特异性抗体药物的研制提供参考。

关键词: BiTE(T-细胞的双特异抗体), 双特异性抗体, 免疫治疗, 组织再生

Abstract: Rapid development of gene engineering has led to the success of the new type of bispecific antibody drugs. At present, the application of dual bispecific antibody drugs was in tumor immunotherapy, autoimmune diseases, infectious diseases, tissue regeneration and clinical diagnosis. In this paper, the brief development history was introduced, and applications of bispecific antibodies in immunological therapy, tissue regeneration and clinical diagnosis were reviewed. At last, development prospect was forecasted. The paper was expected to provided reference for the research and development of new bispecific antibody drugs.

Key words: BiTE (bispecific T cell engager), bispecific antibodies, immunotherapy, regenerative medicine